The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Polymers Drug Delivery-Global Market Insights and Sales Trends 2024
Synopsis
The global Polymers Drug Delivery market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Polymers Drug Delivery in various end use industries. The expanding demands from the Medical Research Center, Pharmaceutical Factory and Other, are propelling Polymers Drug Delivery market. Micelles, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Microgels segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Polymers Drug Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Polymers Drug Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Polymers Drug Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Polymers Drug Delivery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Polymers Drug Delivery covered in this report include Sanofi, Johnson & Johnson, Inovio Pharmaceuticals, Alkermes, Janssen Biotech, Heron, Eisai, Perrigo and Quark Pharmaceuticals Inc, etc.
The global Polymers Drug Delivery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Johnson & Johnson
Inovio Pharmaceuticals
Alkermes
Janssen Biotech
Heron
Eisai
Perrigo
Quark Pharmaceuticals Inc
Vectura Group Plc
SurModics
EnColl Corporation
Enzon Pharmaceuticals
Nektar Therapeutics
Allergan
Gilead Sciences
Tolmar
Global Polymers Drug Delivery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Polymers Drug Delivery market, Segment by Type:
Micelles
Microgels
Dendrimer
Hydrogels
Other
Global Polymers Drug Delivery market, by Application
Medical Research Center
Pharmaceutical Factory
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Polymers Drug Delivery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Polymers Drug Delivery market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Polymers Drug Delivery in various end use industries. The expanding demands from the Medical Research Center, Pharmaceutical Factory and Other, are propelling Polymers Drug Delivery market. Micelles, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Microgels segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Polymers Drug Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Polymers Drug Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Polymers Drug Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Polymers Drug Delivery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Polymers Drug Delivery covered in this report include Sanofi, Johnson & Johnson, Inovio Pharmaceuticals, Alkermes, Janssen Biotech, Heron, Eisai, Perrigo and Quark Pharmaceuticals Inc, etc.
The global Polymers Drug Delivery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Johnson & Johnson
Inovio Pharmaceuticals
Alkermes
Janssen Biotech
Heron
Eisai
Perrigo
Quark Pharmaceuticals Inc
Vectura Group Plc
SurModics
EnColl Corporation
Enzon Pharmaceuticals
Nektar Therapeutics
Allergan
Gilead Sciences
Tolmar
Global Polymers Drug Delivery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Polymers Drug Delivery market, Segment by Type:
Micelles
Microgels
Dendrimer
Hydrogels
Other
Global Polymers Drug Delivery market, by Application
Medical Research Center
Pharmaceutical Factory
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Polymers Drug Delivery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Polymers Drug Delivery
1.1 Polymers Drug Delivery Market Overview
1.1.1 Polymers Drug Delivery Product Scope
1.1.2 Polymers Drug Delivery Market Status and Outlook
1.2 Global Polymers Drug Delivery Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Polymers Drug Delivery Market Size by Region (2018-2029)
1.4 Global Polymers Drug Delivery Historic Market Size by Region (2018-2023)
1.5 Global Polymers Drug Delivery Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Polymers Drug Delivery Market Size (2018-2029)
1.6.1 North America Polymers Drug Delivery Market Size (2018-2029)
1.6.2 Europe Polymers Drug Delivery Market Size (2018-2029)
1.6.3 Asia-Pacific Polymers Drug Delivery Market Size (2018-2029)
1.6.4 Latin America Polymers Drug Delivery Market Size (2018-2029)
1.6.5 Middle East & Africa Polymers Drug Delivery Market Size (2018-2029)
2 Polymers Drug Delivery Market by Type
2.1 Introduction
2.1.1 Micelles
2.1.2 Microgels
2.1.3 Dendrimer
2.1.4 Hydrogels
2.1.5 Other
2.2 Global Polymers Drug Delivery Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Polymers Drug Delivery Historic Market Size by Type (2018-2023)
2.2.2 Global Polymers Drug Delivery Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Polymers Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Polymers Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Polymers Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Polymers Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Polymers Drug Delivery Revenue Breakdown by Type (2018-2029)
3 Polymers Drug Delivery Market Overview by Application
3.1 Introduction
3.1.1 Medical Research Center
3.1.2 Pharmaceutical Factory
3.1.3 Other
3.2 Global Polymers Drug Delivery Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Polymers Drug Delivery Historic Market Size by Application (2018-2023)
3.2.2 Global Polymers Drug Delivery Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Polymers Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Polymers Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Polymers Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Polymers Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Polymers Drug Delivery Revenue Breakdown by Application (2018-2029)
4 Polymers Drug Delivery Competition Analysis by Players
4.1 Global Polymers Drug Delivery Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Polymers Drug Delivery as of 2022)
4.3 Date of Key Players Enter into Polymers Drug Delivery Market
4.4 Global Top Players Polymers Drug Delivery Headquarters and Area Served
4.5 Key Players Polymers Drug Delivery Product Solution and Service
4.6 Competitive Status
4.6.1 Polymers Drug Delivery Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Polymers Drug Delivery Products, Services and Solutions
5.1.4 Sanofi Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.1.5 Sanofi Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Polymers Drug Delivery Products, Services and Solutions
5.2.4 Johnson & Johnson Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson & Johnson Recent Developments
5.3 Inovio Pharmaceuticals
5.3.1 Inovio Pharmaceuticals Profile
5.3.2 Inovio Pharmaceuticals Main Business
5.3.3 Inovio Pharmaceuticals Polymers Drug Delivery Products, Services and Solutions
5.3.4 Inovio Pharmaceuticals Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.3.5 Alkermes Recent Developments
5.4 Alkermes
5.4.1 Alkermes Profile
5.4.2 Alkermes Main Business
5.4.3 Alkermes Polymers Drug Delivery Products, Services and Solutions
5.4.4 Alkermes Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.4.5 Alkermes Recent Developments
5.5 Janssen Biotech
5.5.1 Janssen Biotech Profile
5.5.2 Janssen Biotech Main Business
5.5.3 Janssen Biotech Polymers Drug Delivery Products, Services and Solutions
5.5.4 Janssen Biotech Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.5.5 Janssen Biotech Recent Developments
5.6 Heron
5.6.1 Heron Profile
5.6.2 Heron Main Business
5.6.3 Heron Polymers Drug Delivery Products, Services and Solutions
5.6.4 Heron Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.6.5 Heron Recent Developments
5.7 Eisai
5.7.1 Eisai Profile
5.7.2 Eisai Main Business
5.7.3 Eisai Polymers Drug Delivery Products, Services and Solutions
5.7.4 Eisai Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.7.5 Eisai Recent Developments
5.8 Perrigo
5.8.1 Perrigo Profile
5.8.2 Perrigo Main Business
5.8.3 Perrigo Polymers Drug Delivery Products, Services and Solutions
5.8.4 Perrigo Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.8.5 Perrigo Recent Developments
5.9 Quark Pharmaceuticals Inc
5.9.1 Quark Pharmaceuticals Inc Profile
5.9.2 Quark Pharmaceuticals Inc Main Business
5.9.3 Quark Pharmaceuticals Inc Polymers Drug Delivery Products, Services and Solutions
5.9.4 Quark Pharmaceuticals Inc Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.9.5 Quark Pharmaceuticals Inc Recent Developments
5.10 Vectura Group Plc
5.10.1 Vectura Group Plc Profile
5.10.2 Vectura Group Plc Main Business
5.10.3 Vectura Group Plc Polymers Drug Delivery Products, Services and Solutions
5.10.4 Vectura Group Plc Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.10.5 Vectura Group Plc Recent Developments
5.11 SurModics
5.11.1 SurModics Profile
5.11.2 SurModics Main Business
5.11.3 SurModics Polymers Drug Delivery Products, Services and Solutions
5.11.4 SurModics Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.11.5 SurModics Recent Developments
5.12 EnColl Corporation
5.12.1 EnColl Corporation Profile
5.12.2 EnColl Corporation Main Business
5.12.3 EnColl Corporation Polymers Drug Delivery Products, Services and Solutions
5.12.4 EnColl Corporation Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.12.5 EnColl Corporation Recent Developments
5.13 Enzon Pharmaceuticals
5.13.1 Enzon Pharmaceuticals Profile
5.13.2 Enzon Pharmaceuticals Main Business
5.13.3 Enzon Pharmaceuticals Polymers Drug Delivery Products, Services and Solutions
5.13.4 Enzon Pharmaceuticals Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.13.5 Enzon Pharmaceuticals Recent Developments
5.14 Nektar Therapeutics
5.14.1 Nektar Therapeutics Profile
5.14.2 Nektar Therapeutics Main Business
5.14.3 Nektar Therapeutics Polymers Drug Delivery Products, Services and Solutions
5.14.4 Nektar Therapeutics Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.14.5 Nektar Therapeutics Recent Developments
5.15 Allergan
5.15.1 Allergan Profile
5.15.2 Allergan Main Business
5.15.3 Allergan Polymers Drug Delivery Products, Services and Solutions
5.15.4 Allergan Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.15.5 Allergan Recent Developments
5.16 Gilead Sciences
5.16.1 Gilead Sciences Profile
5.16.2 Gilead Sciences Main Business
5.16.3 Gilead Sciences Polymers Drug Delivery Products, Services and Solutions
5.16.4 Gilead Sciences Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.16.5 Gilead Sciences Recent Developments
5.17 Tolmar
5.17.1 Tolmar Profile
5.17.2 Tolmar Main Business
5.17.3 Tolmar Polymers Drug Delivery Products, Services and Solutions
5.17.4 Tolmar Polymers Drug Delivery Revenue (US$ Million) & (2018-2023)
5.17.5 Tolmar Recent Developments
6 North America
6.1 North America Polymers Drug Delivery Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Polymers Drug Delivery Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Polymers Drug Delivery Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Polymers Drug Delivery Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Polymers Drug Delivery Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Polymers Drug Delivery Market Dynamics
11.1 Polymers Drug Delivery Industry Trends
11.2 Polymers Drug Delivery Market Drivers
11.3 Polymers Drug Delivery Market Challenges
11.4 Polymers Drug Delivery Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
